2022
DOI: 10.1101/2022.03.21.485119
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Deep topographic proteomics of a human brain tumour

Abstract: Cellular protein expression profiles within tissues are key to understanding disease pathology, and their spatial organisation determines cellular function. To precisely define molecular phenotypes in the spatial context of tissue, there is a need for unbiased, quantitative technology capable of mapping the expression of many hundreds to thousands of proteins within tissue structures. Here, we present a workflow for spatially resolved, quantitative proteomics of tissue that generates maps of protein expression… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 96 publications
0
1
0
Order By: Relevance
“…The R code used for analysis can be downloaded from https://zenodo. org/record/8341909 104 . Code for the affinity network fusion analysis can be accessed at https://github.com/pdcharles/spatial-proteomics-anf.…”
Section: Reporting Summarymentioning
confidence: 99%
“…The R code used for analysis can be downloaded from https://zenodo. org/record/8341909 104 . Code for the affinity network fusion analysis can be accessed at https://github.com/pdcharles/spatial-proteomics-anf.…”
Section: Reporting Summarymentioning
confidence: 99%
“…Combinatorial techniques like immunohistochemistry followed by Matrix assisted laser desorption ionisation–mass spectrometry imaging (MALDI-MSI) to visualise spatial distribution of lipids and metabolites in TNBC patient biospecimens would provide region-specific distribution profiles. This could be coupled with laser capture microdissection (LMD) to cut out specific regions of interest (ROI) from the tissues for proteomics profiling with LC-MS/MS [ 101 ]. Mapping the profiling data to the ROIs can provide vital information about the tumour and TME.…”
Section: Future Directionmentioning
confidence: 99%